MongoDB, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MongoDB, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	115	166	267	422	590	874	1,284	1,683	2,006	2,464
Cost of revenue	29.9	42.9	73.6	125	177	259	349	424	535	696
Gross profit	84.9	123	193	296	413	614	935	1,259	1,471	1,768
Research and development	51.8	62.2	89.9	149	205	309	422	516	597	716
Selling and marketing	75.4	109	148	224	325	472	699	783	871	944
General and administrative	27.1	36.8	53.1	71.3	92.3	123	160	194	219	244
Operating expenses	154	208	291	444	623	904	1,281	1,492	1,687	1,905
Operating income	-69.3	-84.9	-97.8	-148	-209	-289	-347	-234	-216	-137
Interest expense	0.01	0.01	10.3	21	56.1	11.3	9.8	9.39	8.09	3.13
Interest income	0.3	1.31
Other non-operating income	-0.31	0.9	-1.44	-15.9	-1.85	-3.14	-1.75	-0.64	-3.13	-4.19
Pre-tax income	-69.3	-82.7	-102	-176	-263	-303	-333	-164	-132	-55.7
Income tax	0.72	1.29	-3.32	-0.66	4.25	3.98	12.1	13.1	-2.53	15.5
Net income	-70.1	-84	-99	-176	-267	-307	-345	-177	-129	-71.2
EBITDA	-65.6	-81.2	-92	-135	-195	-276	-331	-215	-204	-115
EPS, basic	-5.74	-3.54	-1.90	-3.14	-4.53	-4.75	-5.03	-2.48	-1.73	-0.88
EPS, diluted	-5.74	-3.54	-1.90	-3.14	-4.53	-4.75	-5.03	-2.48	-1.73	-0.88
Shares, basic (weighted)	12.2	23.7	52	55.9	59	64.6	68.6	71.2	74.6	81.2
Shares, diluted (weighted)	12.2	23.7	52	55.9	59	64.6	68.6	71.2	74.6	81.2

Balance sheet

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	69.3	61.9	148	706	430	474	456	803	490	1,084
Short-term investments	47.2	217	318	280	528	1,352	1,381	1,212	1,846	1,304
Receivables	31.3	50.6	72.8	85.6	135	195	285	326	393	499
Other current assets	3.13	5.88	11.6	16.9	12.4	32.6	31.2	50.1	81.2	97.2
Total current assets	158	347	566	1,113	1,142	2,117	2,237	2,484	2,924	3,115
Property, plant and equipment	4.88	59.6	73.7	58.3	62.4	62.6	57.8	53	46.4	39.8
Lease right-of-use assets			0	11.1	34.6	41.7	41.2	37.4	34.6	29
Goodwill	1.7	1.7	41.9	55.8	55.8	57.8	69.7	69.7	69.7	191
Intangible assets	2.51	1.63	15.9	34.8	26.3	20.6	11.4	3.96	24.6	34.5
Other non-current assets	6.78	22.4	34.6	54.7	85.6	147	182	218	311	323
Total assets	174	433	733	1,329	1,407	2,450	2,589	2,870	3,430	3,759
Accounts payable	2.84	2.26	2.15	2.85	4.14	5.23	8.3	9.91	10.5	20.3
Accrued liabilities	5.27	8.42	14.2	26.9	56.4	48.8	52.7	74.8	87.7	110
Deferred revenue	78.3	84.4	122	167	221	352	429	357	334	387
Total current liabilities	97.8	113	165	242	355	527	589	564	562	669
Lease liabilities			0	8.11	39.1	38.7	36.3	30.9	27.4	23.6
Other non-current liabilities	0	55.2	69.4	60	59.1	57.7	53	41.7	33	29.5
Total liabilities	116	185	469	1,246	1,408	1,783	1,849	1,801	648	806
Total debt			217
Paid-in capital	62.6	639	755	752	932	1,861	2,277	2,777	4,625	5,345
Retained earnings	-347	-390	-489	-668	-935	-1,190	-1,535	-1,712	-1,841	-1,912
Treasury stock	-1.32	-1.32	-1.32	-1.32	-1.32	-1.32	-1.32	-1.32	-1.32	-495
Other comprehensive income	-0.36	-0.16	-0.17	0.23	-0.7	-2.93	-0.91	4.55	-0.92	13.2
Shareholders' equity	-245	248	265	82.9	-5.03	667	740	1,069	2,782	2,952
Total equity	-245	248	265	82.9	-5.03	667	740	1,069	2,782	2,952
Total liabilities and equity	174	433	733	1,329	1,407	2,450	2,589	2,870	3,430	3,759
Shares outstanding					60.9	67.4	69.9	72.7	80.5	80.5

Cash flow statement

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	-70.1	-84	-99	-176	-267	-307	-345	-177	-129	-71.2
Depreciation and amortization	3.75	3.7	5.79	12.8	14.2	13.7	16.1	18.9	11.8	22.4
Stock-based compensation	21	21.2	37.4	75.8	149	251	381	457	494	550
Deferred income tax	-0	-0.29	-4.97	-3.29	-0.36	-2.53	-0.57	-1.09	-16.8	-3.46
Change in receivables	-11.8	-16.1	-19.4	-12.7	-47.6	-62.3	-91.5	-41.6	-69.2	-106
Change in payables	1.3	-0.37	-0.91	0.51	1.22	1.15	3.16	1.68	0.54	8.92
Cash from operations	-38.1	-44.9	-42	-29.5	-42.7	6.98	-13	121	150	505
Capital expenditures	-1.68	-2.14	-6.85	-3.56	-11.8	-8.07	-7.24	-6.07	-29.6	-4.96
Acquisitions	0	0	-55.5	-38.6	0	-4.47	0	-15	0	-2.03
Purchases of investments	-82	-252	-548	-429	-990	-1,385	-1,448	-1,234	-1,414	-418
Sales and maturities of investments							1,425	1,445	753	845
Cash from investing	31.1	-172	-160	-1.65	-263	-852	-33.3	188	-657	539
Stock issued	0	0	10.5	0	0	889	0	0	1.97	3.18
Share buybacks	-0.05	-0.24	-0.33	-0.04	-0.01	0	0	0	0	-400
Cash from financing	43.1	210	288	589	27.6	891	30.2	38.2	202	-462
Exchange rate effect	0.01	0.29	-0.05	0.31	1.26	-1.53	-2	-0.43	-5.7	12.3
Net change in cash	36.1	-6.99	85.9	558	-276	44.2	-18.1	347	-311	594
Free cash flow	-39.8	-47	-48.8	-33.1	-54.4	-1.09	-20.2	115	121	500
Interest paid	0.02	0.01	1.04	2.38	7	6.27	5.84	5.47	3.71	1.9
Income taxes paid	0.41	1	0.98	2.7	2.31	5.67	11.2	13.6	14.6	14.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $410.44 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	72.7%	Gross profit / revenue.
Operating margin	-0.5%	Operating income / revenue.
EBITDA margin	0.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	2.7%	Pre-tax income / revenue.
Net margin	2.1%	Net income / revenue.
FCF margin	23.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	24.0%	Cash from operations / revenue.
Effective tax rate	22.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	2.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.6%	Net income / average total assets.
Return on invested capital (ROIC)	-0.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	28.0%	Research and development expense / revenue.
Stock-based pay / revenue	20.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.3%	Capital expenditures / revenue.
D&A / revenue	0.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	22.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	24.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	33.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	20.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	23.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	33.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	236.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	314.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	6.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	58.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	9.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	13.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	21.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	9.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	5.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	6.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	4.87x	Current assets / current liabilities.
Quick ratio	4.47x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	3.75x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	21.1%	Total liabilities / total assets.
Interest coverage	-6.14x	Operating income / interest expense.
Working capital	$2.48B	Current assets - current liabilities.
Goodwill and intangibles / assets	6.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.75B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.74x	Revenue / average total assets.
Fixed asset turnover	71.4x	Revenue / average property, plant and equipment.
Receivables turnover	6.07x	Revenue / average receivables.
Days sales outstanding	60 days	365 x average receivables / revenue.
Days payables	8 days	365 x average accounts payable / cost of revenue.
FCF conversion	1,119.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	1.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.72	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$33.94	Revenue / diluted weighted shares.
FCF per share	$8.04	Free cash flow / diluted weighted shares.
Operating cash flow per share	$8.13	Cash from operations / diluted weighted shares.
Book value per share	$36.34	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$33.48	Tangible book value / shares outstanding.
Cash per share	$29.41	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	61.6%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$33.01B	Share price x shares outstanding.
Enterprise value	$30.60B	Market cap + total debt - cash - short-term investments.
P/E	561x	Market cap / net income. Only when net income is positive.
P/S	11.9x	Market cap / revenue.
P/B	11.1x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	12.0x	Market cap / tangible book value, when positive.
P/FCF	50.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	49.5x	Market cap / cash from operations, when positive.
EV/Sales	11.0x	Enterprise value / revenue.
EV/EBITDA	3,652x	Enterprise value / EBITDA, when both are positive.
EV/FCF	46.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	2.0%	Free cash flow / market cap.
Earnings yield	0.2%	Net income / market cap (the inverse of P/E).
Shareholder yield	1.2%	(Dividends paid + share buybacks) / market cap.

What was MongoDB, Inc.'s revenue in fiscal 2026?

MongoDB, Inc. reported revenue of $2.46B for fiscal 2026, 22.8% higher than the year before.

Was MongoDB, Inc. profitable in fiscal 2026?

No. It reported a net loss of $71.2M.

How much free cash flow did MongoDB, Inc. generate in fiscal 2026?

Cash from operations of $505.1M minus capital expenditures of $5.0M left free cash flow of $500.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to MongoDB, Inc.